Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence'. Together they form a unique fingerprint.
Electric Countershock
Medicine & Life Sciences
100%
Anticoagulants
Medicine & Life Sciences
73%
Warfarin
Medicine & Life Sciences
41%
edoxaban
Medicine & Life Sciences
30%
apixaban
Medicine & Life Sciences
27%
Dabigatran
Medicine & Life Sciences
26%
Rivaroxaban
Medicine & Life Sciences
25%
Embolism
Medicine & Life Sciences
20%
Cite this